Join to view full profile
Memorial Sloan Kettering Cancer Center Westchester500 Westchester AvenueNew York, NY 10021
Dr. Lee is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2009 - 2011
University of Michigan Medical SchoolClass of 2009
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2019 - 2025
NY State Medical License 2011 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
Clinical Trials
- CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC) Start of enrollment: 2017 Sep 06
- A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma Start of enrollment: 2018 Aug 13
Publications & Presentations
PubMed
- A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma.Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, Rachel Jacobi, Hyung Jun Woo
European Urology Oncology. 2025-08-01 - 11 citationsSarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors.Ian Nykaza, Yonina R Murciano-Goroff, Antoine Desilets, Guilherme Harada, Michael A Postow
The Oncologist. 2025-05-08 - 2 citationsClinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery.Jennifer Ma, Luke Del Balzo, Henry Walch, Sari Khaleel, Andrea Knezevic
European Urology Oncology. 2025-04-01
Press Mentions
7 Myths About Kidney Cancer, DebunkedApril 19th, 2023
Second-Line Metastatic RCC Outcomes Similar Regardless of First-Line Immunotherapy Combo PartnerNovember 14th, 2022
What Is Kidney Cancer? Symptoms, Causes, Diagnosis, Treatment, and PreventionJune 12th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
